APO Research
Talk to an analyst

APO RESEARCH · REPORT

Celiac Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Celiac Drugs Industry Growth and Trends Forecast to 2032

22 December 2025127 pages

Choose your research edition.

Industry ResearchCeliac Drugs Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Celiac Drugs Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Celiac Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Celiac Drugs Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Celiac Drugs Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Celiac Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Celiac Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Celiac Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Celiac Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Celiac Drugs include Johnson & Johnson, Novartis, Merck, Biogen, Bayer, Amgen, LFB Group, Kedrion Biopharma and Innovate Biopharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Celiac Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Celiac Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Celiac Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Celiac Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Celiac Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Celiac Drugs Market by Company

Johnson & Johnson

Novartis

Merck

Biogen

Bayer

Amgen

LFB Group

Kedrion Biopharma

Innovate Biopharmaceuticals

ImmusanT

Immunomedics

ImmunogenX

F Hoffmann-La Roche

Celimmune

Celgene

Bristol-Myers Squibb

Biotest

BioLineRx

Anthera Pharmaceuticals

ADMA Biologics

Celiac Drugs Segment by Type

First Line Of Treatment

Second Line Of Treatment

Celiac Drugs Segment by Application

Women

Men

Children

Celiac Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Celiac Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Celiac Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Celiac Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Celiac Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Celiac Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of First Line Of Treatment Table 2. Major Company of Second Line Of Treatment Table 3. Global Celiac Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Celiac Drugs Sales by Type (2021-2026) & (k units) Table 5. Global Celiac Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Celiac Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Celiac Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Celiac Drugs Price by Type (2021-2026) & (US$/unit) Table 9. Global Celiac Drugs Sales by Type (2027-2032) & (k units) Table 10. Global Celiac Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Celiac Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Celiac Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Celiac Drugs Price by Type (2027-2032) & (US$/unit) Table 14. North America Celiac Drugs Sales by Type (2021-2026) & (k units) Table 15. North America Celiac Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Celiac Drugs Sales by Type (2021-2026) & (k units) Table 17. Europe Celiac Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Celiac Drugs Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Celiac Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Celiac Drugs Sales by Type (2021-2026) & (k units) Table 21. Latin America Celiac Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Celiac Drugs Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Celiac Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Celiac Drugs Industry Trends Table 25. Celiac Drugs Industry Drivers Table 26. Celiac Drugs Industry Opportunities and Challenges Table 27. Celiac Drugs Industry Restraints Table 28. Global Celiac Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Celiac Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Celiac Drugs Sales by Company (2021-2026) & (k units) Table 31. Global Celiac Drugs Sales Share by Company (2021-2026) Table 32. Global Celiac Drugs Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Celiac Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Celiac Drugs Major Company Production Sites and Headquarters Table 35. Global Celiac Drugs Company, Product Type & Application Table 36. Global Celiac Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Celiac Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Celiac Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Celiac Drugs Sales by Region (2021-2026) & (k units) Table 41. Global Celiac Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Celiac Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Celiac Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Celiac Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Celiac Drugs Sales by Region (2027-2032) & (k units) Table 46. Global Celiac Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Celiac Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Celiac Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Celiac Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Celiac Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Celiac Drugs Sales by Application (2021-2026) & (k units) Table 52. Global Celiac Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Celiac Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Celiac Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Celiac Drugs Price by Application (2021-2026) & (US$/unit) Table 56. Global Celiac Drugs Sales by Application (2027-2032) & (k units) Table 57. Global Celiac Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Celiac Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Celiac Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Celiac Drugs Price by Application (2027-2032) & (US$/unit) Table 61. North America Celiac Drugs Sales by Application (2021-2026) & (k units) Table 62. North America Celiac Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Celiac Drugs Sales by Application (2021-2026) & (k units) Table 64. Europe Celiac Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Celiac Drugs Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Celiac Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Celiac Drugs Sales by Application (2021-2026) & (k units) Table 68. Latin America Celiac Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Celiac Drugs Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Celiac Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Johnson & Johnson Company Information Table 72. Johnson & Johnson Business Overview Table 73. Johnson & Johnson Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Johnson & Johnson Celiac Drugs Product Portfolio Table 75. Johnson & Johnson Recent Development Table 76. Novartis Company Information Table 77. Novartis Business Overview Table 78. Novartis Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Novartis Celiac Drugs Product Portfolio Table 80. Novartis Recent Development Table 81. Merck Company Information Table 82. Merck Business Overview Table 83. Merck Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Merck Celiac Drugs Product Portfolio Table 85. Merck Recent Development Table 86. Biogen Company Information Table 87. Biogen Business Overview Table 88. Biogen Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Biogen Celiac Drugs Product Portfolio Table 90. Biogen Recent Development Table 91. Bayer Company Information Table 92. Bayer Business Overview Table 93. Bayer Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Bayer Celiac Drugs Product Portfolio Table 95. Bayer Recent Development Table 96. Amgen Company Information Table 97. Amgen Business Overview Table 98. Amgen Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Amgen Celiac Drugs Product Portfolio Table 100. Amgen Recent Development Table 101. LFB Group Company Information Table 102. LFB Group Business Overview Table 103. LFB Group Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. LFB Group Celiac Drugs Product Portfolio Table 105. LFB Group Recent Development Table 106. Kedrion Biopharma Company Information Table 107. Kedrion Biopharma Business Overview Table 108. Kedrion Biopharma Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Kedrion Biopharma Celiac Drugs Product Portfolio Table 110. Kedrion Biopharma Recent Development Table 111. Innovate Biopharmaceuticals Company Information Table 112. Innovate Biopharmaceuticals Business Overview Table 113. Innovate Biopharmaceuticals Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Innovate Biopharmaceuticals Celiac Drugs Product Portfolio Table 115. Innovate Biopharmaceuticals Recent Development Table 116. ImmusanT Company Information Table 117. ImmusanT Business Overview Table 118. ImmusanT Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. ImmusanT Celiac Drugs Product Portfolio Table 120. ImmusanT Recent Development Table 121. Immunomedics Company Information Table 122. Immunomedics Business Overview Table 123. Immunomedics Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Immunomedics Celiac Drugs Product Portfolio Table 125. Immunomedics Recent Development Table 126. ImmunogenX Company Information Table 127. ImmunogenX Business Overview Table 128. ImmunogenX Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. ImmunogenX Celiac Drugs Product Portfolio Table 130. ImmunogenX Recent Development Table 131. F Hoffmann-La Roche Company Information Table 132. F Hoffmann-La Roche Business Overview Table 133. F Hoffmann-La Roche Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. F Hoffmann-La Roche Celiac Drugs Product Portfolio Table 135. F Hoffmann-La Roche Recent Development Table 136. Celimmune Company Information Table 137. Celimmune Business Overview Table 138. Celimmune Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. Celimmune Celiac Drugs Product Portfolio Table 140. Celimmune Recent Development Table 141. Celgene Company Information Table 142. Celgene Business Overview Table 143. Celgene Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 144. Celgene Celiac Drugs Product Portfolio Table 145. Celgene Recent Development Table 146. Bristol-Myers Squibb Company Information Table 147. Bristol-Myers Squibb Business Overview Table 148. Bristol-Myers Squibb Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 149. Bristol-Myers Squibb Celiac Drugs Product Portfolio Table 150. Bristol-Myers Squibb Recent Development Table 151. Biotest Company Information Table 152. Biotest Business Overview Table 153. Biotest Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 154. Biotest Celiac Drugs Product Portfolio Table 155. Biotest Recent Development Table 156. BioLineRx Company Information Table 157. BioLineRx Business Overview Table 158. BioLineRx Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 159. BioLineRx Celiac Drugs Product Portfolio Table 160. BioLineRx Recent Development Table 161. Anthera Pharmaceuticals Company Information Table 162. Anthera Pharmaceuticals Business Overview Table 163. Anthera Pharmaceuticals Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 164. Anthera Pharmaceuticals Celiac Drugs Product Portfolio Table 165. Anthera Pharmaceuticals Recent Development Table 166. ADMA Biologics Company Information Table 167. ADMA Biologics Business Overview Table 168. ADMA Biologics Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 169. ADMA Biologics Celiac Drugs Product Portfolio Table 170. ADMA Biologics Recent Development Table 171. North America Celiac Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 172. North America Celiac Drugs Sales by Country (2021-2026) & (k units) Table 173. North America Celiac Drugs Sales Market Share by Country (2021-2026) Table 174. North America Celiac Drugs Sales Forecast by Country (2027-2032) & (k units) Table 175. North America Celiac Drugs Sales Market Share Forecast by Country (2027-2032) Table 176. North America Celiac Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. North America Celiac Drugs Market Size by Country (2021-2026) & (US$ Million) Table 178. North America Celiac Drugs Market Share by Country (2021-2026) Table 179. North America Celiac Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. North America Celiac Drugs Market Share Forecast by Country (2027-2032) Table 181. Europe Celiac Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 182. Europe Celiac Drugs Sales by Country (2021-2026) & (k units) Table 183. Europe Celiac Drugs Sales Market Share by Country (2021-2026) Table 184. Europe Celiac Drugs Sales Forecast by Country (2027-2032) & (k units) Table 185. Europe Celiac Drugs Sales Market Share Forecast by Country (2027-2032) Table 186. Europe Celiac Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Europe Celiac Drugs Market Size by Country (2021-2026) & (US$ Million) Table 188. Europe Celiac Drugs Market Share by Country (2021-2026) Table 189. Europe Celiac Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Europe Celiac Drugs Market Share Forecast by Country (2027-2032) Table 191. Asia-Pacific Celiac Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 192. Asia-Pacific Celiac Drugs Sales by Country (2021-2026) & (k units) Table 193. Asia-Pacific Celiac Drugs Sales Market Share by Country (2021-2026) Table 194. Asia-Pacific Celiac Drugs Sales Forecast by Country (2027-2032) & (k units) Table 195. Asia-Pacific Celiac Drugs Sales Market Share Forecast by Country (2027-2032) Table 196. Asia-Pacific Celiac Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Asia-Pacific Celiac Drugs Market Size by Country (2021-2026) & (US$ Million) Table 198. Asia-Pacific Celiac Drugs Market Share by Country (2021-2026) Table 199. Asia-Pacific Celiac Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Asia-Pacific Celiac Drugs Market Share Forecast by Country (2027-2032) Table 201. Latin America Celiac Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 202. Latin America Celiac Drugs Sales by Country (2021-2026) & (k units) Table 203. Latin America Celiac Drugs Sales Market Share by Country (2021-2026) Table 204. Latin America Celiac Drugs Sales Forecast by Country (2027-2032) & (k units) Table 205. Latin America Celiac Drugs Sales Market Share Forecast by Country (2027-2032) Table 206. Latin America Celiac Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 207. Latin America Celiac Drugs Market Size by Country (2021-2026) & (US$ Million) Table 208. Latin America Celiac Drugs Market Share by Country (2021-2026) Table 209. Latin America Celiac Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 210. Latin America Celiac Drugs Market Share Forecast by Country (2027-2032) Table 211. Middle East and Africa Celiac Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 212. Middle East and Africa Celiac Drugs Sales by Country (2021-2026) & (k units) Table 213. Middle East and Africa Celiac Drugs Sales Market Share by Country (2021-2026) Table 214. Middle East and Africa Celiac Drugs Sales Forecast by Country (2027-2032) & (k units) Table 215. Middle East and Africa Celiac Drugs Sales Market Share Forecast by Country (2027-2032) Table 216. Middle East and Africa Celiac Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 217. Middle East and Africa Celiac Drugs Market Size by Country (2021-2026) & (US$ Million) Table 218. Middle East and Africa Celiac Drugs Market Share by Country (2021-2026) Table 219. Middle East and Africa Celiac Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 220. Middle East and Africa Celiac Drugs Market Share Forecast by Country (2027-2032) Table 221. Key Raw Materials Table 222. Raw Materials Key Suppliers Table 223. Celiac Drugs Distributors List Table 224. Celiac Drugs Customers List Table 225. Research Programs/Design for This Report Table 226. Authors List of This Report Table 227. Secondary Sources Table 228. Primary Sources List of Figures Figure 1. Celiac Drugs Image Figure 2. Global Celiac Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Celiac Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Celiac Drugs Sales (2021-2032) & (k units) Figure 5. First Line Of Treatment Image Figure 6. Global First Line Of Treatment Sales YoY Growth (2021-2032) & (k units) Figure 7. Second Line Of Treatment Image Figure 8. Global Second Line Of Treatment Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Celiac Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Celiac Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Celiac Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Celiac Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Celiac Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Celiac Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Celiac Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Celiac Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Celiac Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Celiac Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Celiac Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Celiac Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Celiac Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Women Image Figure 24. Global Women Sales YoY Growth (2021-2032) & (k units) Figure 25. Men Image Figure 26. Global Men Sales YoY Growth (2021-2032) & (k units) Figure 27. Children Image Figure 28. Global Children Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Celiac Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Celiac Drugs Market Share by Application 2025 VS 2032 Figure 31. North America Celiac Drugs Sales Market Share in Volume by Application in 2025 Figure 32. North America Celiac Drugs Sales Market Share in Value by Application in 2025 Figure 33. Europe Celiac Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Europe Celiac Drugs Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Celiac Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Celiac Drugs Sales Market Share in Value by Application in 2025 Figure 37. Latin America Celiac Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Celiac Drugs Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Celiac Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Celiac Drugs Sales Market Share in Value by Application in 2025 Figure 41. North America Celiac Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Celiac Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Celiac Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Celiac Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Celiac Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Celiac Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Celiac Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Celiac Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Celiac Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Celiac Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Celiac Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Celiac Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Celiac Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Celiac Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Celiac Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Celiac Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Celiac Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Celiac Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Celiac Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Celiac Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Celiac Drugs Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Celiac Drugs Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • First Line Of Treatment
  • Second Line Of Treatment
Applications
  • Women
  • Men
  • Children
Companies covered
  • Johnson & Johnson
  • Novartis
  • Merck
  • Biogen
  • Bayer
  • Amgen
  • LFB Group
  • Kedrion Biopharma
  • Innovate Biopharmaceuticals
  • ImmusanT
  • Immunomedics
  • ImmunogenX
  • F Hoffmann-La Roche
  • Celimmune
  • Celgene
  • Bristol-Myers Squibb
  • Biotest
  • BioLineRx
  • Anthera Pharmaceuticals
  • ADMA Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Celiac Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Celiac Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Celiac Drugs Market by Type
  6. 1.3.1 First Line Of Treatment
  7. 1.3.2 Second Line Of Treatment
  8. 1.4 Global Celiac Drugs Market Size by Type
  9. 1.4.1 Global Celiac Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Celiac Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Celiac Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Celiac Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Celiac Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Celiac Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Celiac Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Celiac Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Celiac Drugs Industry Trends
  2. 2.2 Celiac Drugs Industry Drivers
  3. 2.3 Celiac Drugs Industry Opportunities and Challenges
  4. 2.4 Celiac Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Celiac Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Celiac Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Celiac Drugs Price (2021-2026)
  4. 3.4 Global Celiac Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Celiac Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Celiac Drugs Company, Product Type & Application
  7. 3.7 Global Celiac Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Celiac Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Celiac Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Celiac Drugs Tier 1, Tier 2, and Tier 3
4 Celiac Drugs Regional Status and Outlook
  1. 4.1 Global Celiac Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Celiac Drugs Historic Market Size by Region
  3. 4.2.1 Global Celiac Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Celiac Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Celiac Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Celiac Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Celiac Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Celiac Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Celiac Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Celiac Drugs by Application
  1. 5.1 Celiac Drugs Market by Application
  2. 5.1.1 Women
  3. 5.1.2 Men
  4. 5.1.3 Children
  5. 5.2 Global Celiac Drugs Market Size by Application
  6. 5.2.1 Global Celiac Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Celiac Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Celiac Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Celiac Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Celiac Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Celiac Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Celiac Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Celiac Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Johnson & Johnson
  2. 6.1.1 Johnson & Johnson Company Information
  3. 6.1.2 Johnson & Johnson Business Overview
  4. 6.1.3 Johnson & Johnson Celiac Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Johnson & Johnson Celiac Drugs Product Portfolio
  6. 6.1.5 Johnson & Johnson Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Celiac Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis Celiac Drugs Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Celiac Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Celiac Drugs Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Biogen
  20. 6.4.1 Biogen Company Information
  21. 6.4.2 Biogen Business Overview
  22. 6.4.3 Biogen Celiac Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Biogen Celiac Drugs Product Portfolio
  24. 6.4.5 Biogen Recent Developments
  25. 6.5 Bayer
  26. 6.5.1 Bayer Company Information
  27. 6.5.2 Bayer Business Overview
  28. 6.5.3 Bayer Celiac Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Bayer Celiac Drugs Product Portfolio
  30. 6.5.5 Bayer Recent Developments
  31. 6.6 Amgen
  32. 6.6.1 Amgen Company Information
  33. 6.6.2 Amgen Business Overview
  34. 6.6.3 Amgen Celiac Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Amgen Celiac Drugs Product Portfolio
  36. 6.6.5 Amgen Recent Developments
  37. 6.7 LFB Group
  38. 6.7.1 LFB Group Company Information
  39. 6.7.2 LFB Group Business Overview
  40. 6.7.3 LFB Group Celiac Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 LFB Group Celiac Drugs Product Portfolio
  42. 6.7.5 LFB Group Recent Developments
  43. 6.8 Kedrion Biopharma
  44. 6.8.1 Kedrion Biopharma Company Information
  45. 6.8.2 Kedrion Biopharma Business Overview
  46. 6.8.3 Kedrion Biopharma Celiac Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Kedrion Biopharma Celiac Drugs Product Portfolio
  48. 6.8.5 Kedrion Biopharma Recent Developments
  49. 6.9 Innovate Biopharmaceuticals
  50. 6.9.1 Innovate Biopharmaceuticals Company Information
  51. 6.9.2 Innovate Biopharmaceuticals Business Overview
  52. 6.9.3 Innovate Biopharmaceuticals Celiac Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Innovate Biopharmaceuticals Celiac Drugs Product Portfolio
  54. 6.9.5 Innovate Biopharmaceuticals Recent Developments
  55. 6.10 ImmusanT
  56. 6.10.1 ImmusanT Company Information
  57. 6.10.2 ImmusanT Business Overview
  58. 6.10.3 ImmusanT Celiac Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 ImmusanT Celiac Drugs Product Portfolio
  60. 6.10.5 ImmusanT Recent Developments
  61. 6.11 Immunomedics
  62. 6.11.1 Immunomedics Company Information
  63. 6.11.2 Immunomedics Business Overview
  64. 6.11.3 Immunomedics Celiac Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Immunomedics Celiac Drugs Product Portfolio
  66. 6.11.5 Immunomedics Recent Developments
  67. 6.12 ImmunogenX
  68. 6.12.1 ImmunogenX Company Information
  69. 6.12.2 ImmunogenX Business Overview
  70. 6.12.3 ImmunogenX Celiac Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 ImmunogenX Celiac Drugs Product Portfolio
  72. 6.12.5 ImmunogenX Recent Developments
  73. 6.13 F Hoffmann-La Roche
  74. 6.13.1 F Hoffmann-La Roche Company Information
  75. 6.13.2 F Hoffmann-La Roche Business Overview
  76. 6.13.3 F Hoffmann-La Roche Celiac Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 F Hoffmann-La Roche Celiac Drugs Product Portfolio
  78. 6.13.5 F Hoffmann-La Roche Recent Developments
  79. 6.14 Celimmune
  80. 6.14.1 Celimmune Company Information
  81. 6.14.2 Celimmune Business Overview
  82. 6.14.3 Celimmune Celiac Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Celimmune Celiac Drugs Product Portfolio
  84. 6.14.5 Celimmune Recent Developments
  85. 6.15 Celgene
  86. 6.15.1 Celgene Company Information
  87. 6.15.2 Celgene Business Overview
  88. 6.15.3 Celgene Celiac Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Celgene Celiac Drugs Product Portfolio
  90. 6.15.5 Celgene Recent Developments
  91. 6.16 Bristol-Myers Squibb
  92. 6.16.1 Bristol-Myers Squibb Company Information
  93. 6.16.2 Bristol-Myers Squibb Business Overview
  94. 6.16.3 Bristol-Myers Squibb Celiac Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Bristol-Myers Squibb Celiac Drugs Product Portfolio
  96. 6.16.5 Bristol-Myers Squibb Recent Developments
  97. 6.17 Biotest
  98. 6.17.1 Biotest Company Information
  99. 6.17.2 Biotest Business Overview
  100. 6.17.3 Biotest Celiac Drugs Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Biotest Celiac Drugs Product Portfolio
  102. 6.17.5 Biotest Recent Developments
  103. 6.18 BioLineRx
  104. 6.18.1 BioLineRx Company Information
  105. 6.18.2 BioLineRx Business Overview
  106. 6.18.3 BioLineRx Celiac Drugs Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 BioLineRx Celiac Drugs Product Portfolio
  108. 6.18.5 BioLineRx Recent Developments
  109. 6.19 Anthera Pharmaceuticals
  110. 6.19.1 Anthera Pharmaceuticals Company Information
  111. 6.19.2 Anthera Pharmaceuticals Business Overview
  112. 6.19.3 Anthera Pharmaceuticals Celiac Drugs Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Anthera Pharmaceuticals Celiac Drugs Product Portfolio
  114. 6.19.5 Anthera Pharmaceuticals Recent Developments
  115. 6.20 ADMA Biologics
  116. 6.20.1 ADMA Biologics Company Information
  117. 6.20.2 ADMA Biologics Business Overview
  118. 6.20.3 ADMA Biologics Celiac Drugs Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 ADMA Biologics Celiac Drugs Product Portfolio
  120. 6.20.5 ADMA Biologics Recent Developments
7 North America by Country
  1. 7.1 North America Celiac Drugs Sales by Country
  2. 7.1.1 North America Celiac Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Celiac Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Celiac Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Celiac Drugs Market Size by Country
  6. 7.2.1 North America Celiac Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Celiac Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Celiac Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Celiac Drugs Sales by Country
  2. 8.1.1 Europe Celiac Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Celiac Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Celiac Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Celiac Drugs Market Size by Country
  6. 8.2.1 Europe Celiac Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Celiac Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Celiac Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Celiac Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Celiac Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Celiac Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Celiac Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Celiac Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Celiac Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Celiac Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Celiac Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Celiac Drugs Sales by Country
  2. 10.1.1 South America Celiac Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Celiac Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Celiac Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Celiac Drugs Market Size by Country
  6. 10.2.1 South America Celiac Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Celiac Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Celiac Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Celiac Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Celiac Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Celiac Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Celiac Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Celiac Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Celiac Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Celiac Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Celiac Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Celiac Drugs Value Chain Analysis
  2. 12.1.1 Celiac Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Celiac Drugs Production Mode & Process
  7. 12.2 Celiac Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Celiac Drugs Distributors
  10. 12.2.3 Celiac Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst